Esperion Therapeutics reported $33.97M in Stock for its third fiscal quarter of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Stock Change
Adamas Pharmaceuticals ADMS:US 8.68M 892K
Alexion Pharmaceuticals ALXN:US $ 803.9M 28.2M
Alnylam Pharmaceuticals ALNY:US $ 110.95M 26.59M
Amarin AMRN:US $ 309.27M 36.81M
Amgen AMGN:US $ 4152M 37M
Arena Pharmaceuticals ARNA:US $ 0M 0M
Biogen BIIB:US $ 1347.9M 93.1M
Biomarin Pharmaceutical BMRN:US $ 749.41M 38.43M
Daiichi Sankyo 4568:JP Y 209990M 1818M
Eli Lilly And LLY:US $ 3907.4M 82.5M
Esperion Therapeutics ESPR:US $ 33.97M 10.26M
Flexion Therapeutics FLXN:US $ 14.67M 2.37M
Halozyme Therapeutics HALO:US $ 55.98M 2.58M
Heron Therapeutics HRTX:US $ 41.5M 1.3M
Intra Cellular Therapies ITCI:US $ 8.17M 0.4M
IONIS PHARMACEUT IONS:US $ 22.93M 1.17M
Nektar Therapeutics NKTR:US $ 15.33M 0.71M
Ptc Therapeutics PTCT:US $ 15.61M 0.83M
Puma Biotechnology PBYI:US $ 7.21M 0.41M
Regeneron Pharmaceuticals REGN:US $ 1550.1M 433.8M
Seattle Genetics SGEN:US $ 181.38M 18.19M
United Therapeutics UTHR:US $ 96.7M 6.8M
Vanda Pharmaceuticals VNDA:US 902K 153K
Zogenix ZGNX:US $ 3.5M 0.58M